Bashir MR, Bhatti L, Marin D, Nelson RC.Emerging applications for ferumoxytol as a contrast agent in MRI. J Magn Reson Imaging 2015; 41:884-898. Daldrup-Link HE.Ten things you might not know about iron oxide nanoparticles. Radiology 2017; 284:616-629. ...
MUSIC, multiphase, steady-state imaging with contrast; MRI, magnetic resonance imaging; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; LVEF, left ventricular ejection fraction; RVED...
Ferumoxytol was originally designed more than 20 years ago as a bolus injectable blood pool agent for MRI and was briefly explored for first-pass contrast-enhanced MRdoi:10.1002/jmri.25827J. Paul FinnKim‐Lien NguyenPeng HuJohn Wiley & Sons, LtdJournal of Magnetic Resonance Imaging...
Ferumoxytol is approved by the US FDA for treatment of iron deficiency in certain patients and is used on an investigational basis as an MRI contrast agent. Its iron oxide core is coated in carboxymethyl dextran, and it accumulates in phagocytic macrophages at least in part via the scavenger ...
Cardiovascular MRI with ferumoxytolCardiovascular MRI with ferumoxytolThe practice of contrast-enhanced magnetic resonance angiography (CEMRA) has changed significantly in the span of a decade. Concerns regarding gadolinium (Gd)-associated nephrogenic systemic fibrosis in those with severely impaired renal fun...
MRI with ferumoxytol: a single center experience of safety across the age spectrum. J Magn Reson Imaging. 2017;45(3):804–12. Article PubMed Google Scholar Ning P, et al. Hemodynamic safety and efficacy of ferumoxytol as an intravenous contrast agents in pediatric patients and young adults....
(pFerumoxytol has been examined as a contrast agent for magnetic resonance imaging (MRI) studies. Because ferumoxytol is a very small superparamagnetic iron oxide (USPIO) with a polysaccharide coating, it may be administered via the intravenous bolus route without mast cell degranulation, which is ...
最近,《国家科学评论》(National Science Review顾宁教授团队撰写的综述文章“Unveiling the next generation of MRI contrast agents: current insights and perspectives on ferumoxytol-enhanced MRI”。 在该综述中,作者以医工交叉的视角全面阐述了FE-MRI的临床应用和固有技术优势,弥合了临床需求和工程创新之间的差距,并...
Ferumoxytol Iron Oxide Nanoparticles as a Magnetic Resonance Contrast Agent in Central Nervous System Lesions xi Chapter 1: The Translational Significance of the Neurovascular Unit ... 1 1.1. Abstract ... 2 1.2. NVU Com... H Mcconnell 被引量: 2发表: 2018年 Neurovascular Unit: Basic and Clini...
Ferumoxytol (Feraheme, AMAG Pharmaceuticals, Waltham, MA, USA) is a therapeutic agent used in the treatment of iron-deficient anaemia that has also been applied as a non-gadolinium magnetic resonance imaging (MRI) contrast agent with uses throughout the body. Its unique properties allow it to ...